AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
UV light synergistically enhances the cardiotoxic effects of interleukin 1beta through peroxynitrite formation
Authors: Combes, A McTiernan, C Brooks, SS Feldman, AM
Citation: A. Combes et al., UV light synergistically enhances the cardiotoxic effects of interleukin 1beta through peroxynitrite formation, J CARD FAIL, 7(2), 2001, pp. 165-175
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
Authors: Hunt, SA Baker, DW Chin, MH Cinquegrani, MP Feldman, AM Francis, GS Ganiats, TG Goldstein, S Gregoratos, G Jessup, ML Noble, RJ Packer, M Silver, MA Stevenson, LW Gibbons, RJ Antman, EM Alpert, JS Faxon, DP Fuster, V Gregoratos, G Jacobs, AK Hiratzka, LF Russell, RO Smith, SC
Citation: Sa. Hunt et al., ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure), J AM COL C, 38(7), 2001, pp. 2101-2113
Differential effects of overexpression of two forms of ephrin-A5 on neonatal rat cardiomyocytes
Authors: Li, YY Mi, ZB Feng, YQ McTiernan, CF Zhou, RP Robbins, PD Watkins, SC Feldman, AM
Citation: Yy. Li et al., Differential effects of overexpression of two forms of ephrin-A5 on neonatal rat cardiomyocytes, AM J P-HEAR, 281(6), 2001, pp. H2738-H2746
Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression
Authors: Kadokami, T McTiernan, CF Kubota, T Frye, CS Bounoutas, GS Robbins, PD Watkins, SC Feldman, AM
Citation: T. Kadokami et al., Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression, AM J P-HEAR, 280(5), 2001, pp. H2281-H2291
The pharmacokinetics of etanercept in patients with heart failure
Authors: Soran, O Feldman, AM Schneider, VM Hanna, R Mann, DL Korth-Bradley, JM
Citation: O. Soran et al., The pharmacokinetics of etanercept in patients with heart failure, BR J CL PH, 51(2), 2001, pp. 191-192
The international EECP patient registry (IEPR): Design, methods, baseline characteristics, and acute results
Authors: Barsness, G Feldman, AM Holmes, DR Holubkov, R Kelsey, SF Kennard, ED
Citation: G. Barsness et al., The international EECP patient registry (IEPR): Design, methods, baseline characteristics, and acute results, CLIN CARD, 24(6), 2001, pp. 435-442
Matrix metalloproteinases in pathophysiology and treatment of heart failure
Authors: Feldman, AM Li, YY McTiernan, CF
Citation: Am. Feldman et al., Matrix metalloproteinases in pathophysiology and treatment of heart failure, LANCET, 357(9257), 2001, pp. 654-655
Myocarditis. Reply
Authors: Feldman, AM McNamara, DM
Citation: Am. Feldman et Dm. Mcnamara, Myocarditis. Reply, N ENG J MED, 344(11), 2001, pp. 858-858
Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium
Authors: Kubota, T Miyagishima, M Frye, CS Alber, SM Bounoutas, GS Kadokami, T Watkins, SC McTiernan, CF Feldman, AM
Citation: T. Kubota et al., Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium, J MOL CEL C, 33(7), 2001, pp. 1331-1344
Matrix metalloproteinases in the progression of heart failure - Potential therapeutic implications
Authors: Li, YY Feldman, AM
Citation: Yy. Li et Am. Feldman, Matrix metalloproteinases in the progression of heart failure - Potential therapeutic implications, DRUGS, 61(9), 2001, pp. 1239-1252
Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure - A report from the Vesnarinone Trial
Authors: Deswal, A Petersen, NJ Feldman, AM White, BG Mann, DL
Citation: A. Deswal et al., Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure - A report from the Vesnarinone Trial, CHEST, 120(2), 2001, pp. 453-459
Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity
Authors: Li, YY Chen, DX Watkins, SC Feldman, AM
Citation: Yy. Li et al., Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity, CIRCULATION, 104(20), 2001, pp. 2492-2497
Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model
Authors: Kadokami, T Frye, C Lemster, B Wagner, CL Feldman, AM McTiernan, CF
Citation: T. Kadokami et al., Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model, CIRCULATION, 104(10), 2001, pp. 1094-1097
Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices
Authors: Li, YY Feng, YQ McTiernan, CF Moravec, CS Wang, P Rosenblum, W Kormos, RL Feldman, AM
Citation: Yy. Li et al., Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices, CIRCULATION, 104(10), 2001, pp. 1147-1152
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
Authors: Bozkurt, B Torre-Amione, G Warren, MS Whitmore, J Soran, OZ Feldman, AM Mann, DL
Citation: B. Bozkurt et al., Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure, CIRCULATION, 103(8), 2001, pp. 1044-1047
Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy
Authors: McNamara, DM Holubkov, R Starling, RC Dec, GW Loh, E Torre-Amione, G Gass, A Janosko, K Tokarczyk, T Kessler, P Mann, DL Feldman, AM
Citation: Dm. Mcnamara et al., Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy, CIRCULATION, 103(18), 2001, pp. 2254-2259
Cytokines and cytokine receptors in advanced heart failure - An analysis of the cytokine database from the vesnarinone trial (VEST)
Authors: Deswal, A Petersen, NJ Feldman, AM Young, JB White, BG Mann, DL
Citation: A. Deswal et al., Cytokines and cytokine receptors in advanced heart failure - An analysis of the cytokine database from the vesnarinone trial (VEST), CIRCULATION, 103(16), 2001, pp. 2055-2059
Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure
Authors: McNamara, DM Holubkov, R Janosko, K Palmer, A Wang, JJ MacGowan, GA Murali, S Rosenblum, WD London, B Feldman, AM
Citation: Dm. Mcnamara et al., Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure, CIRCULATION, 103(12), 2001, pp. 1644-1648
Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial
Authors: Bristow, MR Feldman, AM Saxon, LA
Citation: Mr. Bristow et al., Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial, J CARD FAIL, 6(3), 2000, pp. 276-285
From clinical trials to clinical practice: What we know and do not know about beta-blockers and the heart
Authors: Feldman, AM
Citation: Am. Feldman, From clinical trials to clinical practice: What we know and do not know about beta-blockers and the heart, J CARD FAIL, 6(2), 2000, pp. 34-39
Expression of proinflammatory cytokines in the failing human heart: Comparison of recent-onset and end-stage congestive heart failure
Authors: Kubota, T Miyagishima, M Alvarez, RJ Kormos, R Rosenblum, WD Demetris, AJ Semigran, MJ Dec, GW Holubkov, R McTiernan, CF Mann, DL Feldman, AM McNamara, DM
Citation: T. Kubota et al., Expression of proinflammatory cytokines in the failing human heart: Comparison of recent-onset and end-stage congestive heart failure, J HEART LUN, 19(9), 2000, pp. 819-824
Estrogen is associated with improved survival in aging women with congestive heart failure: Analysis of the vesnarinone studies
Authors: Reis, SE Holubkov, R Young, JB White, BG Cohn, JN Feldman, AM
Citation: Se. Reis et al., Estrogen is associated with improved survival in aging women with congestive heart failure: Analysis of the vesnarinone studies, J AM COL C, 36(2), 2000, pp. 529
The role of tumor necrosis factor in the pathophysiology of heart failure
Authors: Feldman, AM Combes, A Wagner, D Kadakomi, T Kubota, T Li, YY McTiernan, C
Citation: Am. Feldman et al., The role of tumor necrosis factor in the pathophysiology of heart failure, J AM COL C, 35(3), 2000, pp. 537-544
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - Pharmacological approaches
Authors: Adams, KF Baughman, KL Dec, WG Elkayam, U Forker, AD Gheorghiade, M Hermann, D Konstam, MA Liu, P Massie, BM Patterson, JH Silver, MA Stevenson, LW Feldman, AM Cohn, JN Francis, GS Greenberg, B Konstam, MA Leier, C Lorell, BH Packer, M Pitt, B Silver, MA Sonnenblick, E Strobeck, J Walsh, R Yusuf, S
Citation: Kf. Adams et al., HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - Pharmacological approaches, PHARMACOTHE, 20(5), 2000, pp. 495-522
Regulating cardiac cytokine expression: The role of the adrenergic nervoussystem
Authors: Feldman, AM
Citation: Am. Feldman, Regulating cardiac cytokine expression: The role of the adrenergic nervoussystem, CRIT CARE M, 28(11), 2000, pp. 3754-3755
Risultati: 1-25 | 26-43